On the other hand, research indicates that microorganisms or their metabolites can stimulate DCs to produce pro-inflammatory cytokines, such as IL-12 and IFN-γ, thereby activating T-helper 1 (Th1) immune responses and enhancing the anti-tumor efficacy of CD8+T cells (55, 56). This evidence concerns the gene CD8A and neoplasm.